Marketed By
Glenmark Pharmaceuticals Ltd
Pack of
15 Tablet
Salt Composition
Telmisartan (40mg) + Amlodipine (5mg) + Chlorthalidone (6.25mg)
Storage
Keep in Cold Place
Contact for Price

Telma ACT 40/5/6.25 mg...
Delivering To: —
All Substitutes
Indication
Triple Combo For Maximum Bp Control
Description
Telma ACT 40/5/6.25mg tablet is an antihypertensive combination medicine. The medicine is used to treat high blood pressure (hypertension) in adults. Its contains three active ingredient is Telmisartan in (40mg) concentration, Amlodipine in (5mg) concentration and Chlorthalidone in (6.25mg) concentration.
They together work to lower the blood pressure effectively, decrease strain on the heart, and lower the risk of cardiovascular complications such as heart attack or stroke. Doctor's prescription is mandatory before using the tablet to avoid complications during the treatment.
Uses
- Treats high blood pressure (Hypertension)
Side Effects
Telma ACT 40/5/6.25mg tablet cause several side effects that are easily manageable with certain treatment options. If any of the following symptoms persist or worsen consult the healthcare professional instantly:
• Fatigue (tiredness)
• Bradycardia
• Gastrointestinal disturbance
• Electrolyte imbalance
• The increased glucose level in the blood
• Postural hypotension
• Angioedema and urticaria
• Visual disturbance
• Breathlessness
• Muscle cramp
• Headache
• Dizziness
• Sleepiness
• Ankle swelling
How To Use
- Doctor prescription is required while using Telma ACT 40/5/6.25mg tablet to ensure safe and effective treatment option.
- The tablet should be taken with or without food at the same time every day to enhance the effectiveness, maintain consistent blood pressure and reduce the risk of side effects.
- Do not crush, chew or break the tablet as it decrease the effectiveness of the medication and alter its absorption.
How It Works
- Telma ACT 40/5/6.25mg tablet contains three drugs that lowers blood pressure by Angiotensin-II (constricts vessels), inhibiting calcium entry into muscles (relaxes vessels), and reducing excess fluid/sodium. Telmisartan(40mg) acts as an angiotensin II receptor blocker (ARB) which preventing vasoconstriction and narrowing of blood vessels.
- Amlodipine (5mg) is a calcium channel blocker that prevents calcium from entering vascular smooth muscle cells, causing blood vessels to relax and widen. Chlorthalidone (6.25mg) is a thiazide like diuretic that reducing fluid volume and improving blood flow.
Safety Advice
Alcohol
UNSAFE
Pregnancy
CONSULT YOUR DOCTOR
Breast Feeding
CONSULT YOUR DOCTOR
Driving
DANGER
Kidney
PRECAUTION
Liver
PRECAUTION
FAQs
Telma tablet is not administered to pregnant and breastfeeding women, kidney or liver patients and people with very low blood pressure.
Telma ACT is used for patients with high blood pressure. It contains three salt formation to help relax blood vessels.
Telma ACT 40/5/6.25mg tablet drug formation is correctly administered by the healthcare professional to ensure safe treatment.
Telma ACT 40/5/6.25mg tablet is used until the doctor advises you to stop it.
Telma ACT 40/5/6.25mg tablet salt composition is Telmisartan (40mg) + Amlodipine (5mg) + Chlorthalidone (6.25mg) that helps to lower high blood pressure (hypertension).
References
• McClellan, K. J., & Markham, A. (1998). Telmisartan. Drugs, 56(6). https://pubmed.ncbi.nlm.nih.gov/9878991/
• Sharpe, M., Jarvis, B., & Goa, K. L. (2001). Telmisartan: a review of its use in hypertension. Drugs, 61(10), 1501-1529. https://pubmed.ncbi.nlm.nih.gov/11558835/
• Wang, J. G., Palmer, B. F., Vogel Anderson, K., & Sever, P. (2023). Amlodipine in the current management of hypertension. The Journal of Clinical Hypertension, 25(9), 801-807. https://pubmed.ncbi.nlm.nih.gov/37551050/
• Şen, S., Demir, M., Yiğit, Z., & Üresin, A. Y. (2018). Efficacy and safety of s-amlodipine 2.5 and 5 mg/d in hypertensive patients who were treatment-naive or previously received antihypertensive monotherapy. Journal of Cardiovascular Pharmacology and Therapeutics, 23(4), 318-328. https://pubmed.ncbi.nlm.nih.gov/29649885/
• RAGHAVENDRA, R., Kota, R. K., Setty, C. M., & PURUSHOTHAM, R. (2009). Formulation and evaluation of fast dissolving chlorthalidone tablets. International journal of pharmacy and pharmaceutical sciences, 1(1), 79-87. https://www.researchgate.net/publication/288455994_Formulation_and_evaluation_of_fast_dissolving_chlorthalidone_tablets
Ratings And Reviews
5.00/5
6 Ratings
5 Star
100.00%
4 Star
0.00%
3 Star
0.00%
2 Star
0.00%
1 Star
0.00%
Michael White
Trustworthy brand
a year ago
Jyoti Agarwal
Excellent quality and value
a year ago
View All Reviews
Related Products
MARKETER DETAILS
Glenmark Pharmaceuticals Ltd
DISCLAIMER
The contents of this website are for informative purposes only. They are not deliberated to be an alternative to any professional medical prescription and treatment. Seek the advice of a qualified health provider for questions regarding the medical condition. Do not ignore any professional medical advice because of something you have read on this website. This website offers links to other websites, thereby enabling you to go to the other website directly. Therefore, Magicine Pharma isn't responsible for the content of the links in the website or links in the linked websites. The links are provided to assist the visitors and are not approved by any professional health provider.









